dr parikh on outcomes from the herkules-3 trial in braf v600e–mutant mcrc
Published 2 weeks ago • 35 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
1:18
a071601: combination therapy in treating braf v600e mutation positive cranionpharyngioma
-
13:59
debate 2: braf mutant mcrc patients - clinical trial
-
1:19
dr. oh on results from the print trial in mcrpc
-
4:35
highlights from asco gu 2022
-
4:46
remembering when the tumor came back
-
10:14
pancreatic cystic neoplasms part 3 - serous cystic neoplasms and spen pancreas - pancreatic tumors
-
34:57
prof. deon venter, rpah medical centre, nsw, austraila
-
1:52
dr. laber on the prodige 35-panoptimox trial in metastatic pancreatic cancer
-
6:30
sabcs 2023: a look into new research for inflammatory breast cancer
-
0:50
updates from a parp inhibitor clinical trial for patients with metastatic pancreatic cancer
-
4:30
real-world pattern of biologic use in patients with inflammatory bowel disease
-
2:27
hnrnpab:a key molecule in early metastasis of pancreatic ductal adenocarcinomas
-
1:33
dr. hussain on the implications of the profound trial in mcrpc
-
1:35
dr. lockhart on next steps for regorafenib and tas-102 in mcrc
-
1:45
the propel clinical trial exploring olaparib plus abiraterone in mcrpc
-
6:30
sabcs 2023: a look into new research for inflammatory breast cancer
-
0:46
copy of dr. bekaii-saab discusses regorafenib use in mcrc
-
1:27
dr. petrylak on pivotal parp inhibitor trials in mcrpc with dna repair mutations
-
0:39
jeffrey meyerhardt, md, mph, on the implications of the beacon phase 3 study in braf-mutant mcrc